The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
HIV-1 Screening Tests-Global Market Insights and Sales Trends 2025
Synopsis
The global HIV-1 Screening Tests market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of HIV-1 Screening Tests in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling HIV-1 Screening Tests market. ELISA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Rapid Tests segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for HIV-1 Screening Tests market, driven by demand from China, the second largest economy with some signs of stabilising, the HIV-1 Screening Tests market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HIV-1 Screening Tests, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global HIV-1 Screening Tests market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global HIV-1 Screening Tests market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HIV-1 Screening Tests sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of HIV-1 Screening Tests covered in this report include Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (US), Thermo-Fisher Scientific Inc (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Hologic, Inc (US) and Alere Inc (US), etc.
The global HIV-1 Screening Tests market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens AG (Germany)
Roche Diagnostics (Switzerland)
Abbott Laboratories (U.S)
Danaher Corporation (US)
Thermo-Fisher Scientific Inc (US)
Merck KGaA (Germany)
Becton, Dickinson and Company (US)
Hologic, Inc (US)
Alere Inc (US)
Bio-Rad Laboratories (US)
Global HIV-1 Screening Tests market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HIV-1 Screening Tests market, Segment by Type:
ELISA
Rapid Tests
Home Access Dried Blood Spot
Global HIV-1 Screening Tests market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of HIV-1 Screening Tests companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global HIV-1 Screening Tests market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of HIV-1 Screening Tests in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling HIV-1 Screening Tests market. ELISA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Rapid Tests segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for HIV-1 Screening Tests market, driven by demand from China, the second largest economy with some signs of stabilising, the HIV-1 Screening Tests market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HIV-1 Screening Tests, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global HIV-1 Screening Tests market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global HIV-1 Screening Tests market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HIV-1 Screening Tests sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of HIV-1 Screening Tests covered in this report include Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (US), Thermo-Fisher Scientific Inc (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Hologic, Inc (US) and Alere Inc (US), etc.
The global HIV-1 Screening Tests market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens AG (Germany)
Roche Diagnostics (Switzerland)
Abbott Laboratories (U.S)
Danaher Corporation (US)
Thermo-Fisher Scientific Inc (US)
Merck KGaA (Germany)
Becton, Dickinson and Company (US)
Hologic, Inc (US)
Alere Inc (US)
Bio-Rad Laboratories (US)
Global HIV-1 Screening Tests market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HIV-1 Screening Tests market, Segment by Type:
ELISA
Rapid Tests
Home Access Dried Blood Spot
Global HIV-1 Screening Tests market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of HIV-1 Screening Tests companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of HIV-1 Screening Tests
1.1 HIV-1 Screening Tests Market Overview
1.1.1 HIV-1 Screening Tests Product Scope
1.1.2 HIV-1 Screening Tests Market Status and Outlook
1.2 Global HIV-1 Screening Tests Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global HIV-1 Screening Tests Market Size by Region (2018-2029)
1.4 Global HIV-1 Screening Tests Historic Market Size by Region (2018-2023)
1.5 Global HIV-1 Screening Tests Market Size Forecast by Region (2024-2029)
1.6 Key Regions, HIV-1 Screening Tests Market Size (2018-2029)
1.6.1 North America HIV-1 Screening Tests Market Size (2018-2029)
1.6.2 Europe HIV-1 Screening Tests Market Size (2018-2029)
1.6.3 Asia-Pacific HIV-1 Screening Tests Market Size (2018-2029)
1.6.4 Latin America HIV-1 Screening Tests Market Size (2018-2029)
1.6.5 Middle East & Africa HIV-1 Screening Tests Market Size (2018-2029)
2 HIV-1 Screening Tests Market by Type
2.1 Introduction
2.1.1 ELISA
2.1.2 Rapid Tests
2.1.3 Home Access Dried Blood Spot
2.2 Global HIV-1 Screening Tests Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global HIV-1 Screening Tests Historic Market Size by Type (2018-2023)
2.2.2 Global HIV-1 Screening Tests Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America HIV-1 Screening Tests Revenue Breakdown by Type (2018-2029)
2.3.2 Europe HIV-1 Screening Tests Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific HIV-1 Screening Tests Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America HIV-1 Screening Tests Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa HIV-1 Screening Tests Revenue Breakdown by Type (2018-2029)
3 HIV-1 Screening Tests Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global HIV-1 Screening Tests Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global HIV-1 Screening Tests Historic Market Size by Application (2018-2023)
3.2.2 Global HIV-1 Screening Tests Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America HIV-1 Screening Tests Revenue Breakdown by Application (2018-2029)
3.3.2 Europe HIV-1 Screening Tests Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific HIV-1 Screening Tests Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America HIV-1 Screening Tests Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa HIV-1 Screening Tests Revenue Breakdown by Application (2018-2029)
4 HIV-1 Screening Tests Competition Analysis by Players
4.1 Global HIV-1 Screening Tests Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV-1 Screening Tests as of 2022)
4.3 Date of Key Players Enter into HIV-1 Screening Tests Market
4.4 Global Top Players HIV-1 Screening Tests Headquarters and Area Served
4.5 Key Players HIV-1 Screening Tests Product Solution and Service
4.6 Competitive Status
4.6.1 HIV-1 Screening Tests Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Siemens AG (Germany)
5.1.1 Siemens AG (Germany) Profile
5.1.2 Siemens AG (Germany) Main Business
5.1.3 Siemens AG (Germany) HIV-1 Screening Tests Products, Services and Solutions
5.1.4 Siemens AG (Germany) HIV-1 Screening Tests Revenue (US$ Million) & (2018-2023)
5.1.5 Siemens AG (Germany) Recent Developments
5.2 Roche Diagnostics (Switzerland)
5.2.1 Roche Diagnostics (Switzerland) Profile
5.2.2 Roche Diagnostics (Switzerland) Main Business
5.2.3 Roche Diagnostics (Switzerland) HIV-1 Screening Tests Products, Services and Solutions
5.2.4 Roche Diagnostics (Switzerland) HIV-1 Screening Tests Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Diagnostics (Switzerland) Recent Developments
5.3 Abbott Laboratories (U.S)
5.3.1 Abbott Laboratories (U.S) Profile
5.3.2 Abbott Laboratories (U.S) Main Business
5.3.3 Abbott Laboratories (U.S) HIV-1 Screening Tests Products, Services and Solutions
5.3.4 Abbott Laboratories (U.S) HIV-1 Screening Tests Revenue (US$ Million) & (2018-2023)
5.3.5 Danaher Corporation (US) Recent Developments
5.4 Danaher Corporation (US)
5.4.1 Danaher Corporation (US) Profile
5.4.2 Danaher Corporation (US) Main Business
5.4.3 Danaher Corporation (US) HIV-1 Screening Tests Products, Services and Solutions
5.4.4 Danaher Corporation (US) HIV-1 Screening Tests Revenue (US$ Million) & (2018-2023)
5.4.5 Danaher Corporation (US) Recent Developments
5.5 Thermo-Fisher Scientific Inc (US)
5.5.1 Thermo-Fisher Scientific Inc (US) Profile
5.5.2 Thermo-Fisher Scientific Inc (US) Main Business
5.5.3 Thermo-Fisher Scientific Inc (US) HIV-1 Screening Tests Products, Services and Solutions
5.5.4 Thermo-Fisher Scientific Inc (US) HIV-1 Screening Tests Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo-Fisher Scientific Inc (US) Recent Developments
5.6 Merck KGaA (Germany)
5.6.1 Merck KGaA (Germany) Profile
5.6.2 Merck KGaA (Germany) Main Business
5.6.3 Merck KGaA (Germany) HIV-1 Screening Tests Products, Services and Solutions
5.6.4 Merck KGaA (Germany) HIV-1 Screening Tests Revenue (US$ Million) & (2018-2023)
5.6.5 Merck KGaA (Germany) Recent Developments
5.7 Becton, Dickinson and Company (US)
5.7.1 Becton, Dickinson and Company (US) Profile
5.7.2 Becton, Dickinson and Company (US) Main Business
5.7.3 Becton, Dickinson and Company (US) HIV-1 Screening Tests Products, Services and Solutions
5.7.4 Becton, Dickinson and Company (US) HIV-1 Screening Tests Revenue (US$ Million) & (2018-2023)
5.7.5 Becton, Dickinson and Company (US) Recent Developments
5.8 Hologic, Inc (US)
5.8.1 Hologic, Inc (US) Profile
5.8.2 Hologic, Inc (US) Main Business
5.8.3 Hologic, Inc (US) HIV-1 Screening Tests Products, Services and Solutions
5.8.4 Hologic, Inc (US) HIV-1 Screening Tests Revenue (US$ Million) & (2018-2023)
5.8.5 Hologic, Inc (US) Recent Developments
5.9 Alere Inc (US)
5.9.1 Alere Inc (US) Profile
5.9.2 Alere Inc (US) Main Business
5.9.3 Alere Inc (US) HIV-1 Screening Tests Products, Services and Solutions
5.9.4 Alere Inc (US) HIV-1 Screening Tests Revenue (US$ Million) & (2018-2023)
5.9.5 Alere Inc (US) Recent Developments
5.10 Bio-Rad Laboratories (US)
5.10.1 Bio-Rad Laboratories (US) Profile
5.10.2 Bio-Rad Laboratories (US) Main Business
5.10.3 Bio-Rad Laboratories (US) HIV-1 Screening Tests Products, Services and Solutions
5.10.4 Bio-Rad Laboratories (US) HIV-1 Screening Tests Revenue (US$ Million) & (2018-2023)
5.10.5 Bio-Rad Laboratories (US) Recent Developments
6 North America
6.1 North America HIV-1 Screening Tests Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe HIV-1 Screening Tests Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific HIV-1 Screening Tests Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America HIV-1 Screening Tests Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa HIV-1 Screening Tests Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 HIV-1 Screening Tests Market Dynamics
11.1 HIV-1 Screening Tests Industry Trends
11.2 HIV-1 Screening Tests Market Drivers
11.3 HIV-1 Screening Tests Market Challenges
11.4 HIV-1 Screening Tests Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
